Trgovina Black Diamond Therapeutics, Inc. - BDTX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.0356 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024874% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.002651% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 1.7873 |
Odpri* | 1.7673 |
Enoletna sprememba* | -35.73% |
Dnevni razpon* | 1.7673 - 1.8672 |
Razpon 52 wk | 1.18-4.08 |
Povprečni obseg (10 dni) | 74.40K |
Povprečni obseg (3 meseci) | 2.77M |
Tržna kapitalizacija | 66.03M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 36.48M |
Prihodki | N/A |
EPS | -2.51 |
Dividenda (donosnost v %) | N/A |
Beta | -100.00K |
Datum naslednjega zaslužka | May 9, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 1.8672 | 0.0599 | 3.31% | 1.8073 | 1.8672 | 1.7573 |
Mar 30, 2023 | 1.7873 | -0.0200 | -1.11% | 1.8073 | 1.8472 | 1.7074 |
Mar 29, 2023 | 1.8472 | 0.0199 | 1.09% | 1.8273 | 1.8872 | 1.7573 |
Mar 28, 2023 | 1.8473 | 0.0500 | 2.78% | 1.7973 | 1.8473 | 1.7274 |
Mar 27, 2023 | 1.8073 | 0.0299 | 1.68% | 1.7774 | 1.8073 | 1.7074 |
Mar 24, 2023 | 1.8073 | 0.0300 | 1.69% | 1.7773 | 1.8572 | 1.7773 |
Mar 23, 2023 | 1.8372 | 0.0299 | 1.65% | 1.8073 | 1.9072 | 1.7773 |
Mar 22, 2023 | 1.7973 | -0.0499 | -2.70% | 1.8472 | 1.9072 | 1.7673 |
Mar 21, 2023 | 1.8972 | 0.2197 | 13.10% | 1.6775 | 1.8972 | 1.6775 |
Mar 20, 2023 | 1.6875 | 0.0899 | 5.63% | 1.5976 | 1.6875 | 1.5676 |
Mar 17, 2023 | 1.5976 | -0.0699 | -4.19% | 1.6675 | 1.6875 | 1.5776 |
Mar 16, 2023 | 1.6375 | -0.0100 | -0.61% | 1.6475 | 1.7074 | 1.6175 |
Mar 15, 2023 | 1.6775 | -0.0100 | -0.59% | 1.6875 | 1.7374 | 1.5976 |
Mar 14, 2023 | 1.7474 | 0.1698 | 10.76% | 1.5776 | 1.7774 | 1.5376 |
Mar 13, 2023 | 1.5177 | 0.2197 | 16.93% | 1.2980 | 1.9072 | 1.2980 |
Mar 10, 2023 | 1.3180 | -0.1298 | -8.97% | 1.4478 | 1.4478 | 1.2181 |
Mar 9, 2023 | 1.4478 | -0.1897 | -11.58% | 1.6375 | 2.1968 | 1.4378 |
Mar 8, 2023 | 1.6775 | 0.0799 | 5.00% | 1.5976 | 1.7274 | 1.5676 |
Mar 7, 2023 | 1.6675 | -0.1298 | -7.22% | 1.7973 | 1.7973 | 1.6675 |
Mar 6, 2023 | 1.7873 | -0.0399 | -2.18% | 1.8272 | 1.8872 | 1.7773 |
Black Diamond Therapeutics, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 92.828 | 126.872 | 69.57 | 29.332 | 8.904 |
Celotna prodaja/splošni/upravni stroški Odhodki | 28.391 | 30.043 | 21.361 | 7.579 | 1.954 |
Raziskave in razvoj | 64.437 | 96.829 | 48.209 | 21.753 | 6.95 |
Nenavadni odhodki (prihodki) | 0 | ||||
Prihodki iz poslovanja | -92.828 | -126.872 | -69.57 | -29.332 | -8.904 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.219 | 3.464 | 4.041 | -5.932 | -0.011 |
Drugo, neto | -0.354 | -2.188 | -1.725 | 0.006 | -0.016 |
Čisti dobiček pred obdavčitvijo | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Čisti dobiček po davkih | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Čisti dobiček pred dodatnimi postavkami | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Čisti dobiček | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Popravljen čisti dobiček | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
Popravljene ponderirane povprečne delnice | 36.3256 | 36.189 | 32.9071 | 32.6364 | 32.6364 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -2.50977 | -3.47056 | -2.04375 | -1.08033 | -0.27365 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Popravljen normalizirani dobiček na enoto čistega dobička | -2.57122 | -3.47056 | -2.04375 | -1.08033 | -0.27365 |
Gain (Loss) on Sale of Assets | 2.232 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 21.852 | 22.124 | 23.173 | 25.679 | 26.08 |
Celotna prodaja/splošni/upravni stroški Odhodki | 7.243 | 6.277 | 6.978 | 7.893 | 6.416 |
Raziskave in razvoj | 14.609 | 15.847 | 16.195 | 17.786 | 19.664 |
Prihodki iz poslovanja | -21.852 | -22.124 | -23.173 | -25.679 | -26.08 |
Prihodki (odhodki) od obresti, neto Neoperativni | -1.573 | 0.562 | 0.386 | 0.406 | 0.588 |
Drugo, neto | 0.115 | -0.092 | -0.143 | -0.234 | -0.375 |
Čisti dobiček pred obdavčitvijo | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Čisti dobiček po davkih | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Čisti dobiček pred dodatnimi postavkami | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Čisti dobiček | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Popravljen čisti dobiček | -21.078 | -21.654 | -22.93 | -25.507 | -25.867 |
Popravljene ponderirane povprečne delnice | 36.3902 | 36.3462 | 36.2939 | 36.2713 | 36.2303 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.57922 | -0.59577 | -0.63179 | -0.70323 | -0.71396 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.64056 | -0.59577 | -0.63179 | -0.70323 | -0.71396 |
Gain (Loss) on Sale of Assets | 2.232 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 215.703 | 319.554 | 155.714 | 51.684 | 7.914 |
Denarna sredstva in kratkoročne naložbe | 209.786 | 315.067 | 154.666 | 51.66 | 7.878 |
Denarna sredstva in ustrezniki | 65.799 | 34.605 | 154.666 | 51.66 | 7.878 |
Prepaid Expenses | 5.917 | 4.487 | 1.048 | 0.024 | 0.036 |
Total Assets | 247.682 | 329.67 | 158.295 | 51.826 | 8.021 |
Property/Plant/Equipment, Total - Net | 30.74 | 8.787 | 0.164 | 0.134 | 0.102 |
Property/Plant/Equipment, Total - Gross | 31.109 | 8.951 | 0.276 | 0.234 | 0.158 |
Accumulated Depreciation, Total | -0.369 | -0.164 | -0.112 | -0.1 | -0.056 |
Other Long Term Assets, Total | 1.239 | 1.329 | 2.417 | 0.008 | 0.005 |
Total Current Liabilities | 23.642 | 14.218 | 4.863 | 2.575 | 2.23 |
Accounts Payable | 4.107 | 2.538 | 1.964 | 0.416 | 0.152 |
Accrued Expenses | 19.535 | 11.68 | 2.899 | 0.452 | 0.158 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 1.707 | 1.92 | ||
Total Liabilities | 51.782 | 21.912 | 4.879 | 6.598 | 2.238 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 28.14 | 7.694 | 0.016 | 4.023 | 0.008 |
Total Equity | 195.9 | 307.758 | 153.416 | 45.228 | 5.783 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 60.77 | 12.458 | |
Common Stock | 0.005 | 0.005 | 0.001 | 0.001 | 0.001 |
Additional Paid-In Capital | 440.129 | 425.363 | 3.812 | 0.169 | 0.105 |
Retained Earnings (Accumulated Deficit) | -243.82 | -118.224 | -50.97 | -15.712 | -6.781 |
Total Liabilities & Shareholders’ Equity | 247.682 | 329.67 | 158.295 | 51.826 | 8.021 |
Total Common Shares Outstanding | 36.2346 | 36.0784 | 32.6364 | 32.6364 | 32.6364 |
Redeemable Preferred Stock | 0 | 0 | 200.573 | ||
Kratkoročne naložbe | 143.987 | 280.462 | |||
Other Equity, Total | -0.414 | 0.614 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 188.304 | 215.703 | 241.546 | 270.947 | 297.347 |
Denarna sredstva in kratkoročne naložbe | 179.739 | 209.786 | 235.008 | 263.47 | 290.055 |
Denarna sredstva in ustrezniki | 54.081 | 65.799 | 46.603 | 37.324 | 14.105 |
Kratkoročne naložbe | 125.658 | 143.987 | 188.405 | 226.146 | 275.95 |
Prepaid Expenses | 8.565 | 5.917 | 6.538 | 7.477 | 7.292 |
Total Assets | 219.482 | 247.682 | 274.126 | 287.882 | 313.259 |
Property/Plant/Equipment, Total - Net | 29.945 | 30.74 | 31.258 | 15.614 | 14.589 |
Property/Plant/Equipment, Total - Gross | 30.439 | 31.109 | 31.504 | 15.817 | 14.772 |
Accumulated Depreciation, Total | -0.494 | -0.369 | -0.246 | -0.203 | -0.183 |
Other Long Term Assets, Total | 1.233 | 1.239 | 1.322 | 1.321 | 1.323 |
Total Current Liabilities | 19.469 | 23.642 | 26.361 | 23.486 | 18.704 |
Accounts Payable | 1.883 | 4.107 | 4.859 | 5.03 | 4.616 |
Accrued Expenses | 17.586 | 19.535 | 21.502 | 18.456 | 14.088 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 46.922 | 51.782 | 55.178 | 36.862 | 32.506 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 27.453 | 28.14 | 28.817 | 13.376 | 13.802 |
Total Equity | 172.56 | 195.9 | 218.948 | 251.02 | 280.753 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
Additional Paid-In Capital | 443.657 | 440.129 | 436.753 | 433.68 | 428.938 |
Retained Earnings (Accumulated Deficit) | -269.327 | -243.82 | -217.953 | -182.876 | -148.525 |
Other Equity, Total | -1.775 | -0.414 | 0.143 | 0.211 | 0.335 |
Total Liabilities & Shareholders’ Equity | 219.482 | 247.682 | 274.126 | 287.882 | 313.259 |
Total Common Shares Outstanding | 36.2876 | 36.2346 | 36.2289 | 36.2058 | 36.1472 |
Redeemable Preferred Stock | 0 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -125.596 | -67.254 | -35.258 | -8.931 | -4.602 |
Denarna sredstva iz poslovanja | -100.148 | -52.146 | -24.674 | -8.454 | -2.351 |
Denarna sredstva iz poslovanja | 0.205 | 0.052 | 0.047 | 0.044 | 0.024 |
Nedenarne postavke | 18.223 | 10.014 | 10.074 | 0.079 | 0.483 |
Spremembe v obratnem kapitalu | 7.02 | 5.042 | 0.463 | 0.354 | 1.744 |
Denarna sredstva pri naložbenju | 130.613 | -281.691 | -0.021 | -0.076 | -0.077 |
Kapitalski izdatki | -2.71 | -0.142 | -0.021 | -0.076 | -0.077 |
Celotne druge postavke denarnih tokov pri naložbenju | 133.323 | -281.549 | 0 | 0 | |
Denarna sredstva pri financiranju | 0.729 | 214.944 | 127.756 | 52.312 | 9.974 |
Postavke denarnega toka pri financiranju | 0 | -1.743 | 0 | 0 | |
Izdaja (odplačilo) delnic, neto | 0.729 | 214.944 | 129.499 | 52.312 | 10.024 |
Izdaja (odplačilo) dolga, neto | 0 | -0.05 | |||
Neto sprememba denarnih sredstev | 31.194 | -118.893 | 103.061 | 43.782 | 7.546 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.507 | -125.596 | -99.729 | -64.652 | -30.301 |
Cash From Operating Activities | -28.6 | -100.148 | -76.102 | -49.62 | -24.455 |
Cash From Operating Activities | 0.125 | 0.205 | 0.082 | 0.039 | 0.019 |
Non-Cash Items | 4.293 | 18.223 | 13.794 | 9.712 | 4.134 |
Changes in Working Capital | -7.511 | 7.02 | 9.751 | 5.281 | 1.693 |
Cash From Investing Activities | 16.729 | 130.613 | 87.371 | 51.674 | 3.474 |
Capital Expenditures | -0.007 | -2.71 | -2.377 | -0.888 | -0.04 |
Other Investing Cash Flow Items, Total | 16.736 | 133.323 | 89.748 | 52.562 | 3.514 |
Cash From Financing Activities | 0.153 | 0.729 | 0.729 | 0.665 | 0.481 |
Issuance (Retirement) of Stock, Net | 0.153 | 0.729 | 0.729 | 0.665 | 0.481 |
Net Change in Cash | -11.718 | 31.194 | 11.998 | 2.719 | -20.5 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Bellevue Asset Management AG | Investment Advisor | 14.8045 | 5400839 | 87850 | 2022-12-31 | LOW |
New Enterprise Associates (NEA) | Venture Capital | 9.4535 | 3448757 | -1088 | 2022-12-31 | LOW |
RA Capital Management, LP | Hedge Fund | 7.0993 | 2589904 | 0 | 2022-12-31 | LOW |
Boxer Capital, L.L.C. | Hedge Fund | 5.523 | 2014858 | 0 | 2022-12-31 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 4.5133 | 1646517 | 0 | 2022-12-31 | LOW |
Epstein (David M) | Individual Investor | 2.5725 | 938479 | -23090 | 2022-03-15 | LOW |
Citadel Advisors LLC | Hedge Fund | 2.1211 | 773798 | 733149 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.0766 | 757585 | 487 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.7856 | 651395 | -182376 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.4379 | 524557 | 177577 | 2022-12-31 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 0.9763 | 356164 | -66329 | 2022-12-31 | HIGH |
Newtyn Management, LLC | Hedge Fund | 0.8635 | 315000 | -35000 | 2022-12-31 | MED |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.7831 | 285681 | -70820 | 2022-12-31 | LOW |
EcoR1 Capital, LLC | Hedge Fund | 0.7734 | 282131 | 282131 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7272 | 265290 | 743 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.6047 | 220613 | 2913 | 2022-12-31 | HIGH |
K2 & Associates Investment Management Inc. | Hedge Fund | 0.4336 | 158192 | -873319 | 2022-12-31 | HIGH |
Federated Hermes MDTA LLC | Investment Advisor/Hedge Fund | 0.4255 | 155219 | -4329 | 2022-12-31 | HIGH |
BioImpact Capital LLC | Investment Advisor/Hedge Fund | 0.3972 | 144888 | -95000 | 2022-12-31 | LOW |
Tekla Capital Management LLC | Investment Advisor | 0.3618 | 131990 | 0 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Black Diamond Therapeutics, Inc. Company profile
O družbi Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. je podjetje za precizno onkološko medicino. Podjetje se osredotoča na odkrivanje in razvoj terapij z majhnimi molekulami in metodo MasterKey. Ustvarja nabor inhibitorjev kinaz z majhnimi molekulami, ki so usmerjeni proti številnim gonilnim mutacijam pri raku. Njena tehnološka platforma Mutation-Allostery-Pharmacology (MAP) je zasnovana tako, da ji omogoča analizo podatkov o genetskem zaporedju na ravni populacije za odkrivanje onkogenih mutacij, ki spodbujajo raka pri različnih vrstah tumorjev. Njen vodilni kandidat za izdelek, BDTX-189, je zasnovan kot peroralno dostopen, ireverzibilen inhibitor majhnih molekul, ki cilja na spekter 48 nekanoničnih in kanoničnih gonilnih mutacij kinaz ErbB receptorja za epidermalni rastni faktor (EGFR) in HER2. BDTX-1535 je možganski inhibitor, ki je usmerjen proti spektru mutacij EGFR, vključno z alosteričnimi in kanoničnimi mutacijami. Ima tudi programe v zgodnji fazi, kot sta protoonkogen B-Raf (BRAF) in receptor za fibroblastni rastni dejavnik (FGFR).
Industry: | Bio Therapeutic Drugs |
One Main Street, 14Th Floor
CAMBRIDGE
MASSACHUSETTS 02142
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com